Back to Search
ANNA D'AMICO, MD
MD
Obstetrics & Gynecology Physician
NPI: 1740362607Individual
Specialties, Licenses & Credentials
Obstetrics & Gynecology PhysicianPrimary
Obstetrics & Gynecology
Code: 207V00000X
MD014746E(PA)
Research & Publications (20)
Risk of death from prostate cancer after brachytherapy alone or with radiation, androgen suppression therapy, or both in men with high-risk disease.
PMID 19597029·J Clin Oncol·2009
8-other
Interval to testosterone recovery after hormonal therapy for prostate cancer and risk of death.
PMID 19395184·Int J Radiat Oncol Biol Phys·2009
4-observational
Risk of prostate cancer recurrence in men treated with radiation alone or in conjunction with combined or less than combined androgen suppression therapy.
PMID 18565884·J Clin Oncol·2008
2-rct
Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial.
PMID 18212313·JAMA·2008
4-observational
Tumor volume changes on 1.5 tesla endorectal MRI during neoadjuvant androgen suppression therapy for higher-risk prostate cancer and recurrence in men treated using radiation therapy results of the phase II CALGB 9682 study.
PMID 18037582·Int J Radiat Oncol Biol Phys·2008
3-trial
Causes of death in men undergoing androgen suppression therapy for newly diagnosed localized or recurrent prostate cancer.
PMID 18980297·Cancer·2008
8-other
p53 protein expression status and recurrence in men treated with radiation and androgen suppression therapy for higher-risk prostate cancer: a prospective phase II Cancer and Leukemia Group B Study (CALGB 9682).
PMID 18291508·Urology·2008
3-trial
Short- vs long-term androgen suppression plus external beam radiation therapy and survival in men of advanced age with node-negative high-risk adenocarcinoma of the prostate.
PMID 17397033·Cancer·2007
4-observational
Time to an undetectable prostate-specific antigen (PSA) after androgen suppression therapy for postoperative or postradiation PSA recurrence and prostate cancer-specific mortality.
PMID 17315162·Cancer·2007
8-other
Duration of testosterone suppression and the risk of death from prostate cancer in men treated using radiation and 6 months of hormone therapy.
PMID 17828774·Cancer·2007
8-other
Prostate cancer-specific mortality after radical prostatectomy or external beam radiation therapy in men with 1 or more high-risk factors.
PMID 17530618·Cancer·2007
8-other
Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions.
PMID 17557956·J Clin Oncol·2007
8-other
Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial.
PMID 17196507·Lancet Oncol·2007
4-observational
Six-month androgen suppression plus radiation therapy compared with radiation therapy alone for men with prostate cancer and a rapidly increasing pretreatment prostate-specific antigen level.
PMID 16943536·J Clin Oncol·2006
4-observational
Fatal hypertrophic cardiomyopathy and nemaline myopathy associated with ACTA1 K336E mutation.
PMID 16945537·Neuromuscul Disord·2006
5-case
Identifying men diagnosed with clinically localized prostate cancer who are at high risk for death from prostate cancer.
PMID 17084157·J Urol·2006
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2106 SILVERSIDE RD
WILMINGTON, DE 19810 - Phone
- (302) 477-9660
Quick Facts
- NPI
- 1740362607
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile